Indefinite Delivery Contract 75A50122D00003
Award Date
2/22/22
Last Date to Order
2/21/26
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded an Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of vaccines and pharmaceuticals. The 5-year IDC, valued up to $5.87 billion, is for the provision of medical countermeasures to address emerging public health threats, including pandemic influenza. Under this contract, Sanofi Pasteur has received multiple firm...
This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Sanofi Pasteur Inc. as the prime contractor. The IDC has a ceiling value of $6,294,039,491.48 and a period of performance through May 30, 2026. The purpose of the IDC is to facilitate the development and domestic manufacture of adjuvanted, pandemic influenza vaccines to support public...
The federal contract IDV awarded to Sanofi Pasteur Inc. is a multiple award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), with a ceiling value of $634,000,000 and a period of performance through April 14, 2027. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides a range of vaccine and pharmaceutical products to various federal agencies through this IDV and other contract vehicles. The task orders issued under this IDV cover the...
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded an indefinite delivery contract to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to provide a range of pharmaceutical products and services under the Pandemic Influenza Preparedness and Response 2016-2021 program. The $2.11 billion multiple award contract has no set-aside designation and supports government efforts for disease prevention,...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $640,309,577 multiple-award contract, identified as VFA 2009, has an ultimate completion date of June 30, 2010. Under this IDC, Sanofi Pasteur Inc. is the prime contractor responsible for providing a range of vaccine products and services to support various federal...
This Indefinite Delivery Contract (IDC) was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods. The IDC has a ceiling value of $645,550.20 and an ultimate completion date of November 13, 2024. Sanofi Pasteur Inc. has previously received awards from various federal agencies to supply vaccines and other medical countermeasures through IDVs and Federal Supply...
Sanofi Pasteur Inc. was awarded a single-award indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention potentially valued at $64 million. The contract provides for the delivery of seasonal influenza vaccines to support public health programs as outlined in Section 317(j) of the Public Health Service Act. Performance will occur at the prime contractor's manufacturing facility in Swiftwater, Pennsylvania or other locations as needed to...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $82,229,910.30 contract provides seasonal and pre-pandemic influenza vaccines, as well as other standard immunizations, to support disease prevention and public health preparedness for federal agencies. The IDC is a multiple award vehicle with a ceiling value of $82,229,910.30 and a period of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at a ceiling of $669,123,533.05, is for the provision of various vaccine products and related services to support public health missions across multiple federal agencies. The scope of the IDC includes seasonal and pre-pandemic influenza vaccines,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods. The $26.5 million single-award IDC, awarded on March 15, 2010 with a final completion date of February 28, 2011, provides for the delivery of a variety of vaccine products and related services to support the CDC's public health preparedness and...